ATI Oncology Questions Related

Review ATI Oncology Questions related questions and content

A client is receiving rituximab and asks how it works. What response by the nurse is best?

  • A. It causes rapid lysis of the cancer cell membranes.
  • B. It destroys the enzymes needed to create cancer cells.
  • C. It prevents the start of cell division in the cancer cells.
  • D. It sensitizes certain cancer cells to chemotherapy.
Correct Answer: C

Rationale: Rituximab is a monoclonal antibody that targets CD20, a protein found on the surface of certain B-cells, including some cancerous B-cells, such as in non-Hodgkin's lymphoma and chronic lymphocytic leukemia (CLL). Rituximab works by binding to the CD20 protein, which leads to the destruction of the cancerous B-cells through various mechanisms, including preventing the initiation of cell division. By blocking the division process, rituximab helps slow the growth and proliferation of cancer cells, allowing the immune system and additional treatments to clear them more effectively.